Board approves Q2 results, MD re-appointment, new plant expansion

Management Changes View source PDF Explain this filing

ORIENTCER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.1%Reaction day

₹35.70

prior close

₹41.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+10.3% vs market

Electrodes & Refractories peers, median of 10sector-0.2%+10.3% vs sector

On the reaction day the stock moved 10.3 pts more than Nifty Microcap 250 and 10.3 pts more than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.8

10m

-6.1

15m

-4.3

30m

-4.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.1-0.3+10.3-0.2+10.3

Next day

+7.4+0.7+6.8+0.7+6.7

+6.4+0.6+5.9+0.7+5.8

+7.0+0.5+6.5+1.1+5.9

+13.7+1.1+12.6+0.7+13.0

+18.8+0.3+18.5+0.1+18.7

+14.9-0.2+15.1+0.4+14.5

15d

+26.9-2.2+29.2+0.0+26.9

+18.5-4.9+23.4-2.5+21.0

+28.7-7.5+36.2-5.3+34.0

+21.4-4.8+26.1+1.0+20.4

UpDownMarket · Nifty Microcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 FY26 results: standalone revenue up to Rs 115.52 crore versus Rs 72.53 crore YoY, net profit Rs 6.10 crore versus Rs 1.75 crore. H1 profit Rs 9.22 crore. Mr. Manan Shah re-appointed as MD for 5 years from April 2026. Mrs. Akhila Agnihotri Samdaria joined as Independent Director; Mrs. Neeta Shah resigned. Subsidiary OAMPL plans new foundry and resin coating plant by Q4 FY26.

Likely market impact

Strong earnings growth and expansion plans signal positive momentum. Leadership continuity with MD re-appointment provides stability for shareholders.